Monoclonal Antibody-Based Therapies in the Treatment of Acute Lymphoblastic Leukemia

Recent studies have suggested that pediatric-intensive chemotherapy regimens can improve outcomes in adults with acute lymphoblastic leukemia (ALL) up to the age of 45. Above this age, toxicities i...